DFWIX
Price
$19.27
Change
-$0.14 (-0.72%)
Updated
Jun 3 closing price
Net Assets
5.61B
VTISX
Price
$195.31
Change
-$1.59 (-0.81%)
Updated
Jun 3 closing price
Net Assets
629.15B
Interact to see
Advertisement

DFWIX vs VTISX

Header iconDFWIX vs VTISX Comparison
Open Charts DFWIX vs VTISXBanner chart's image
DFWIX vs VTISX Comparison Chart in %
View a ticker or compare two or three
VS
DFWIX vs. VTISX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DFWIX is a Buy and VTISX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTISX has more cash in the bank: 629B vs. DFWIX (5.61B). DFWIX pays higher dividends than VTISX: DFWIX (2.81) vs VTISX (2.66). DFWIX was incepted earlier than VTISX: DFWIX (13 years) vs VTISX (10 years). DFWIX (0.30) is less costly to investors than VTISX (0.05). DFWIX is a more actively managed with annual turnover of: 8.00 vs. VTISX (4.00). DFWIX has a lower initial minimum investment than VTISX: DFWIX (0) vs VTISX (3000000000). DFWIX annual gain was more profitable for investors over the last year : 34.25 vs. VTISX (30.44). DFWIX return over 5 years is better than : 54.27 vs. VTISX (35.05).
DFWIXVTISXDFWIX / VTISX
Total Expense Ratio0.300.05652%
Annual Report Gross Expense Ratio0.300.05652%
Fund Existence13 years10 years-
Gain YTD15.42715.351100%
Front LoadN/AN/A-
Min. Initial Investment03000000000-
Min. Initial Investment IRAN/AN/A-
Net Assets5.61B629B1%
Annual Yield % from dividends2.812.66105%
Returns for 1 year34.2530.44113%
Returns for 3 years75.1160.55124%
Returns for 5 years54.2735.05155%
Returns for 10 years141.51107.81131%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EPSM1.560.15
+10.64%
Epsium Enterprise Limited
REGN618.9516.03
+2.66%
Regeneron Pharmaceuticals
IEP7.46-0.07
-0.93%
Icahn Enterprises LP
IKT1.68-0.02
-1.18%
Inhibikase Therapeutics
SMPL11.42-0.39
-3.30%
Simply Good Foods Company (The)